HS2 Cost Overruns Reach 1027bn Sparks Calls for Cancellation Amid SunkCost Concerns BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development WMS Q1 2026 Earnings EPS Surges Past Estimates Stock Dips 12 Prediction Markets Point to Potential Federal Reserve Rate Hike by July 2027 Torrid Holdings CURV Q1 2026 Earnings EPS Beat Masks Underlying Demand Challenges CTAS Q1 2026 Earnings EPS Slightly Misses Estimates Despite Positive Stock Reaction AILed Workforce Reductions No Guaranteed Stock Market Boost Data Suggests